Levitz Michael L has filed 22 insider transactions across 1 company since March 2023.
Most recent transaction: a grant/award of 21329 shares of Anika Therapeutics, Inc. ($ANIK) on March 15, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 15, 2024 | Anika Therapeutics, Inc. | $ANIK | Levitz Michael L | EVP, CFO, Treasurer | A | Restricted Stock Unit | 21329 | $0.00 | 21,329.0000 | 14,656,000 | 9999.99% | 0.15% |
| March 15, 2024 | Anika Therapeutics, Inc. | $ANIK | Levitz Michael L | EVP, CFO, Treasurer | A | Stock Option (Right to Buy) | 51682 | $0.00 | 51,682.0000 | 14,656,000 | 9999.99% | 0.35% |
| March 11, 2024 | Anika Therapeutics, Inc. | $ANIK | Levitz Michael L | EVP, CFO, Treasurer | M | Common Stock | 4438 | $0.00 | 37,830.0000 | 14,656,000 | 13.29% | 0.03% |
| March 11, 2024 | Anika Therapeutics, Inc. | $ANIK | Levitz Michael L | EVP, CFO, Treasurer | F | Common Stock | 1303 | $25.42 | 36,527.0000 | 14,656,000 | 3.44% | 0.01% |
| March 11, 2024 | Anika Therapeutics, Inc. | $ANIK | Levitz Michael L | EVP, CFO, Treasurer | M | Common Stock | 5875 | $0.00 | 42,402.0000 | 14,656,000 | 16.08% | 0.04% |
| March 11, 2024 | Anika Therapeutics, Inc. | $ANIK | Levitz Michael L | EVP, CFO, Treasurer | F | Common Stock | 1725 | $25.42 | 40,677.0000 | 14,656,000 | 4.07% | 0.01% |
| March 11, 2024 | Anika Therapeutics, Inc. | $ANIK | Levitz Michael L | EVP, CFO, Treasurer | M | Common Stock | 8888 | $0.00 | 49,565.0000 | 14,656,000 | 21.85% | 0.06% |
| March 11, 2024 | Anika Therapeutics, Inc. | $ANIK | Levitz Michael L | EVP, CFO, Treasurer | F | Common Stock | 2610 | $25.79 | 46,955.0000 | 14,656,000 | 5.27% | 0.02% |
| March 11, 2024 | Anika Therapeutics, Inc. | $ANIK | Levitz Michael L | EVP, CFO, Treasurer | M | Restricted Stock Unit | 4438 | $0.00 | 0.0000 | 14,656,000 | 100.00% | 0.03% |
| March 11, 2024 | Anika Therapeutics, Inc. | $ANIK | Levitz Michael L | EVP, CFO, Treasurer | M | Restricted Stock Unit | 5875 | $0.00 | 11,749.0000 | 14,656,000 | 33.34% | 0.04% |
| March 11, 2024 | Anika Therapeutics, Inc. | $ANIK | Levitz Michael L | EVP, CFO, Treasurer | M | Restricted Stock Unit | 8888 | $0.00 | 8,888.0000 | 14,656,000 | 50.00% | 0.06% |
| Aug. 10, 2023 | Anika Therapeutics, Inc. | $ANIK | Levitz Michael L | EVP, CFO, Treasurer | M | Common Stock | 3859 | $0.00 | 34,365.0000 | 14,787,000 | 12.65% | 0.03% |
| Aug. 10, 2023 | Anika Therapeutics, Inc. | $ANIK | Levitz Michael L | EVP, CFO, Treasurer | F | Common Stock | 1133 | $18.58 | 33,232.0000 | 14,787,000 | 3.30% | 0.01% |
| Aug. 10, 2023 | Anika Therapeutics, Inc. | $ANIK | Levitz Michael L | EVP, CFO, Treasurer | M | Restricted Stock Unit | 3859 | $0.00 | 0.0000 | 14,787,000 | 100.00% | 0.03% |
| March 10, 2023 | Anika Therapeutics, Inc. | $ANIK | Levitz Michael L | EVP, CFO, Treasurer | M | Common Stock | 8888 | $0.00 | 32,447.0000 | 14,787,000 | 37.73% | 0.06% |
| March 10, 2023 | Anika Therapeutics, Inc. | $ANIK | Levitz Michael L | EVP, CFO, Treasurer | F | Common Stock | 2609 | $26.10 | 29,838.0000 | 14,787,000 | 8.04% | 0.02% |
| March 10, 2023 | Anika Therapeutics, Inc. | $ANIK | Levitz Michael L | EVP, CFO, Treasurer | M | Restricted Stock Unit | 8888 | $0.00 | 17,776.0000 | 14,787,000 | 33.33% | 0.06% |
| March 9, 2023 | Anika Therapeutics, Inc. | $ANIK | Levitz Michael L | EVP, CFO, Treasurer | M | Common Stock | 4439 | $0.00 | 24,862.0000 | 14,787,000 | 21.74% | 0.03% |
| March 9, 2023 | Anika Therapeutics, Inc. | $ANIK | Levitz Michael L | EVP, CFO, Treasurer | F | Common Stock | 1303 | $26.91 | 23,559.0000 | 14,787,000 | 5.24% | 0.01% |
| March 9, 2023 | Anika Therapeutics, Inc. | $ANIK | Levitz Michael L | EVP, CFO, Treasurer | A | Restricted Stock Unit | 17624 | $0.00 | 17,624.0000 | 14,787,000 | 9999.99% | 0.12% |
| March 9, 2023 | Anika Therapeutics, Inc. | $ANIK | Levitz Michael L | EVP, CFO, Treasurer | A | Stock Option (Right to Buy) | 38475 | $0.00 | 38,475.0000 | 14,787,000 | 9999.99% | 0.26% |
| March 9, 2023 | Anika Therapeutics, Inc. | $ANIK | Levitz Michael L | EVP, CFO, Treasurer | M | Restricted Stock Unit | 4439 | $0.00 | 4,438.0000 | 14,787,000 | 50.01% | 0.03% |